News from REMEDY

Marianne Skaar presents the EULAR recommendations for how user stakeholders should be involved in research on rheumatic diseases. The recommendations were updated in 2023.

The very first biopsies in the Start project were a starting shot for the operational part of an ambitious research work. If you want, it will make major contributions to diagnostics and treatment for patients with inflammatory arthritis.

Diakonhjemmet Foundation now becomes a partner in Health2B and a player in the arena of health innovation. This marks an important milestone in the development of sustainable solutions for health services.

How can the healthcare system handle chronic diseases in the future? Hege Johanne Magnussen has researched this and interviewed patients and healthcare personnel about the course of hand osteoarthritis. What contributes to and what stands in the way of the transfer of responsibilities, roles and tasks between practitioners and levels in the healthcare service?

In 2024, Diakonhjemmet Hospital set a new record with 14 doctorates in one year. This marks an important milestone in the work for better treatment and healthcare services. It is the result of a long-term commitment to research and innovation for the benefit of patients. Seven of the doctorates come from the REMEDY center. 

More than 50,000 Norwegians are taking a common type of medicine to suppress their immune system. A new study shows that these patients are no longer at high risk of severe COVID-19.

Conducting clinical trials requires more than just researchers. Support personnel handle rules, applications and documents. They also contribute to good communication in the studies.